Sierra Oncology, Inc.
USD54.99
+0.00 (+0.00%)
CEO
Nicholas Glover
IPO Date
2015-07-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$54.98
Prev. Close
$54.99
Day Low
$54.98
Day High
$55.01
52W Low
$14.91
52W High
$55.19
| -2.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -102.2% | -58.3% | 0.01 | 2.32 | -0.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -56.5% | -48.7% | 0.05 | 10.77 | -1.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -44.4% | -41.1% | 0.00 | 13.61 | -4.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -46.4% | -43.1% | 0.00 | 14.28 | -0.9 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -36.6% | -34.9% | 0.00 | 20.53 | -0.4 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -65.3% | -58.9% | 0.00 | 18.96 | -1.0 |
| 31 Dec 2013 | FY | 0.0% | 0.0% | -977.4% | -277.7% | 0.59 | 2.74 | -4.5 |
| -3.3 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -30.1% | -27.5% | 0.01 | 11.91 | -2.6 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -24.5% | -21.9% | 0.01 | 9.80 | -2.9 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -19.6% | -18.0% | 0.00 | 12.34 | -2.5 |
| 31 Dec 2020 | Q4 | 100.0% | -9011.5% | -18.4% | -16.8% | 0.00 | 11.38 | -2.5 |
| 30 Sept 2020 | Q3 | 100.0% | -14505.0% | -13.8% | -12.8% | 0.00 | 15.00 | -1.9 |
| 30 Jun 2020 | Q2 | 0.0% | 0.0% | -14.1% | -13.1% | 0.00 | 13.88 | -1.9 |
| 31 Mar 2020 | Q1 | 0.0% | 0.0% | -24.6% | -23.3% | 0.00 | 19.36 | -0.8 |
| 31 Dec 2019 | Q4 | 0.0% | 0.0% | -55.0% | -31.4% | 0.01 | 2.32 | -0.4 |